Get started

Agilent

Agilent Reports Second-Quarter Fiscal Year 2024 Financial ResultAgilent Technologies Inc. (NYSE: NYSE:A ) reported a revenue of $1.57 billion for the second quarter of fiscal year 2024, down 8.4% reported and 7.4% core compared to the second quarter of 2023. GAAP net income was $308 million, with earnings per share (EPS) of $1.05, up 3% from the second quarter of 2023. Non-GAAP(2) net income was $356 million, with EPS of $1.22, down 4% from the second quarter of 2023. The full-year revenue outlook was revised at $6.420 billion to $6.500 billion, representing a range of down 6.0% to 4.9% on a reported basis and down 5.4% to 4.3% core. Fiscal year 2024 non-GAAP(3) earnings guidance was revised at a range of $5.15 to $5.25 per share. The company plans to repurchase $0.75 billion of its common stock by the end of the fiscal year, and the board recently authorized a new $2.0 billion share repurchase program. The company's president and CEO, Padraig McDonnell, expressed confidence in the future and excited about the opportunities that lie ahead for Agilent. In the first quarter of 2024, Agilent (NYSE: NYSE:A ) implemented certain changes to its segment reporting structure, which have no impact on its consolidated financial statements. The Life Sciences and Applied Markets Group reported second-quarter revenue of $754 million, a decline of 14% reported and 13% core year-over-year. The Agilent CrossLab Group (NYSE: NYSE:A ) reported second-quarter revenue of $402 million, an increase of 4% reported and 5% core year-over-year. The Diagnostics and Genomics Group reported second-quarter revenue of $417 million, a decrease of 9% reported and 8% core year-over-year. The full-year revenue outlook is revised at $6.420 billion to $6.500 billion, representing a range of down 6.0% to 4.9% on a reported basis and down 5.4% to 4.3% core. The outlook for third-quarter revenue is expected in the range of $1.535 billion to $1.575 billion, a decline of 8.2% to 5.8% reported and 6.9% to 4.5% core. Technical Outlook Agilent ( NYSE:A ) stock is down 18.36% in pre-market trading on Thursday starting on a rough slate it technically means Agilent stock is in a oversold region forming a downside gap. Gapping occurs in trading when there is no trading activities that occur but a stock is under-performing or outperforming prior to a fundamental.
NYSE:AShort
by DEXWireNews
$A god move coming~After the amazing impulsive move to an ATH we came back to the 61 fib line which is a great pullback and a healthy one. ~we are in a wedge rn and are looking at a breakout next week ~~Bull flag highlighted in white looking hella fine, hinting at a breakout happening for the bulls ~Red zone is SL ~Green zone is take Profit max ~white zones in between will be key resistance points. ~VI indicator shows momentum is about to turn back to bullish. With earnings coming up on the 22nd, this could be a run-up to earnings play
NYSE:ALong
by CheckMatted
$AAgilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets: Food Environmental and Forensics Pharmaceutical Diagnostics Chemical and Energy & Research It’s no doubt, this company has seen incredible growth seeing over 200% since the COVID lows. But in my honest opinion, the valuation is ridiculous. Agilent Technologies is starting to look like a “Parabolic Curve Step-like Formation” on the monthly timeframe w/ the RSI ridiculously oversold. - 5.90 on the daily. - 10.96 on the weekly. - 90.00 0n the monthly. MACD overstretched. - 5.90 on the daily - 10.96 on the weekly - 20.98 on the monthly I suggest keeping this on your watchlist. - Factor Four
NYSE:AShort
by TheBlankFund
2
Agilent Technologies Pullback to 93This is a very bullish pair but pullbacks are always do at some point. This is a quick in and out play down to the 93 level as this was the previous swing high. This is a technical trade based off a break and retest of structure, concurrently having the 1 hour and 4 hour 50EMA lining up at the same area, as well as the 382 fib retracement. Stop loss is placed right above the 618 retracement and target is the 272 extension which coincides with the 93 level where the last structure was broken.
NYSE:AShort
by respvwned
A - Is Agilent Topping Out or It's Just Me?There was a predominant uptrend at least throughout 2017 (it made about 45% after first breaking out in Jan '17). However, with the increased volatility in the general market and in this stock's price action specifically, the wedge pattern forming can be expected to progress for at least quick bearish pullback. That is where I'm placing my bets. At least if the uptrend is to continue, I am bearish for now as the stock takes a breather after the 2017 run up. Stop @ 70.56 Target @ 65.31
NYSE:AShort
by themdtrader